HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease.

AuthorsB Kleedorfer, A J Lees, G M Stern
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 54 Issue 4 Pg. 373 (Apr 1991) ISSN: 0022-3050 [Print] England
PMID2056330 (Publication Type: Comparative Study, Letter)
Chemical References
  • Antiparkinson Agents
  • Levodopa
  • levodopa methyl ester
Topics
  • Administration, Sublingual
  • Antiparkinson Agents
  • Drug Administration Schedule
  • Female
  • Humans
  • Injections, Subcutaneous
  • Levodopa (administration & dosage, analogs & derivatives)
  • Male
  • Middle Aged
  • Neurologic Examination
  • Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: